계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Cero Therapeutics
company
About
CERo Therapeutics, Inc. is a new cellular immunotherapy company.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $40M
- Industries
- Biotechnology,Therapeutics
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
CERo Therapeutics, Inc. is a new cellular immunotherapy company. We have created a hybrid platform that integrates innate and adaptive programs to eliminate disease.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$40M
Cero Therapeutics has raised a total of
$40M
in funding over 2 rounds. Their latest funding was raised on
Mar 18, 2020 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 18, 2020 | Series A | $40M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Cero Therapeutics is funded by 2 investors.
Lyell Immunopharma
and ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Lyell Immunopharma
|
— | Series A |
ARCH Venture Partners
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
